Literature DB >> 18463931

A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations.

Nicola Scopinaro1, Francesco Papadia, Giovanni Camerini, Giuseppe Marinari, Dario Civalleri, Adami Gian Franco.   

Abstract

BACKGROUND: Roux-en-Y gastric bypass (RYGBP) and biliopancreatic diversion (BPD) are highly beneficial operations for type 2 diabetes mellitus (T2DM) in obese patients, leading to complete T2DM resolution in 75-90 and 97-99% of cases, respectively. In both RYGBP and BPD, the foregut is excluded from the food stream and the distal small bowel receives the food stimulation, while following BPD fat intestinal absorption is also extremely limited. This study was carried out to identify clinical features that could give insight on the different mechanisms of action on diabetes resolution.
METHODS: The files of 443 severely obese patients with T2DM undergoing BPD from May 1976 to May 2007 were examined, and the presence of T2DM (fasting serum glucose >125 mg/ml) at 1-2 months, at 1 year, at 10 years, and at > or =20 years following the operation was recorded.
RESULTS: The percentage of patients cured (fasting serum glucose reduced to < or =110 mg/dl, on free diet and with no therapy) was 74% at 1 month, 97% at 1 and 10 years, and 91% at > or =20 years, the 26% of uncured patients at 1 month being those with most severe preoperative T2DM.
CONCLUSIONS: As the early results after BPD resemble those reported after RYGBP, it can be hypothesized that the duodenal exclusion and the distal small bowel stimulation are the first mechanisms acting in BPD, immediately after the operation, that only subsequently the myocellular fat depletion, which cannot be immediate, takes over, and that the minimal fat absorption is the mechanism accounting for the long-term results of BPD.

Entities:  

Mesh:

Year:  2008        PMID: 18463931     DOI: 10.1007/s11695-008-9531-x

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  30 in total

1.  Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery.

Authors:  Stefania Camastra; Melania Manco; Andrea Mari; Aldo V Greco; Silvia Frascerra; Geltrude Mingrone; Ele Ferrannini
Journal:  Diabetes Care       Date:  2007-04       Impact factor: 19.112

2.  Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function.

Authors:  A Mari; M Manco; C Guidone; G Nanni; M Castagneto; G Mingrone; E Ferrannini
Journal:  Diabetologia       Date:  2006-07-04       Impact factor: 10.122

Review 3.  Potential of surgery for curing type 2 diabetes mellitus.

Authors:  Francesco Rubino; Michel Gagner
Journal:  Ann Surg       Date:  2002-11       Impact factor: 12.969

4.  GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects.

Authors:  Rosa Morínigo; Antonio M Lacy; Roser Casamitjana; Salvadora Delgado; Ramon Gomis; Josep Vidal
Journal:  Obes Surg       Date:  2006-12       Impact factor: 4.129

5.  Magnetic resonance spectroscopy facilitates assessment of intramyocellular lipid changes: a preliminary short-term study following biliopancreatic diversion.

Authors:  Gian Franco Adami; Roberto Carlo Parodi; Francesco Papadia; Giuseppe Marinari; Giovanni Camerini; Roberta Corvisieri; Nicola Scopinaro
Journal:  Obes Surg       Date:  2005-10       Impact factor: 4.129

6.  Etiology of type II diabetes mellitus: role of the foregut.

Authors:  W J Pories; R J Albrecht
Journal:  World J Surg       Date:  2001-04-18       Impact factor: 3.352

7.  Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

Authors:  Francesco Rubino; Jacques Marescaux
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

8.  Biliopancreatic diversion.

Authors:  N Scopinaro; G F Adami; G M Marinari; E Gianetta; E Traverso; D Friedman; G Camerini; G Baschieri; A Simonelli
Journal:  World J Surg       Date:  1998-09       Impact factor: 3.352

9.  Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion.

Authors:  Lucia Briatore; Barbara Salani; Gabriella Andraghetti; Cristina Danovaro; Elsa Sferrazzo; Nicola Scopinaro; Gian F Adami; Davide Maggi; Renzo Cordera
Journal:  Obesity (Silver Spring)       Date:  2008-01       Impact factor: 5.002

10.  Recovery of insulin sensitivity in obese patients at short term after biliopancreatic diversion.

Authors:  Gian Franco Adami; Renzo Cordera; Giovanni Camerini; Giuseppe M Marinari; Nicola Scopinaro
Journal:  J Surg Res       Date:  2003-08       Impact factor: 2.192

View more
  17 in total

1.  Long-term results of biliopancreatic diversion with or without gastric preservation for morbid obesity.

Authors:  Nicola Crea; Giacomo Pata; Ernesto Di Betta; Francesco Greco; Claudio Casella; Antonio Vilardi; Francesco Mittempergher
Journal:  Obes Surg       Date:  2011-02       Impact factor: 4.129

2.  Surgery needs better support from EU.

Authors:  Nicola Di Lorenzo; Valeria Tognoni; Luca Iezzi; Achille Lucio Gaspari
Journal:  Surg Endosc       Date:  2011-02       Impact factor: 4.584

Review 3.  Biological effects of bariatric surgery on obesity-related comorbidities.

Authors:  Sabrena F Noria; Teodor Grantcharov
Journal:  Can J Surg       Date:  2013-02       Impact factor: 2.089

4.  [Indications and principles of metabolic surgery].

Authors:  R A Weiner
Journal:  Chirurg       Date:  2010-04       Impact factor: 0.955

5.  Biliopancreatic Diversion in the Surgical Treatment of Morbid Obesity: Long-Term Results and Metabolic Consequences.

Authors:  Alessandro Bianchi; Alberto Pagan-Pomar; Marina Jimenez-Segovia; José Antonio Martinez-Corcoles; Francesc Xavier Gonzalez-Argenté
Journal:  Obes Surg       Date:  2020-06-19       Impact factor: 4.129

Review 6.  Resolution of type 2 diabetes following bariatric surgery: implications for adults and adolescents.

Authors:  Radha Nandagopal; Rebecca J Brown; Kristina I Rother
Journal:  Diabetes Technol Ther       Date:  2010-08       Impact factor: 6.118

7.  Predictors for remission of major components of the metabolic syndrome after biliopancreatic diversion with duodenal switch (BPDDS).

Authors:  Villy Våge; Roy M Nilsen; Arnold Berstad; Jan Behme; Nils Sletteskog; Ronny Gåsdal; Camilla Laukeland; Gunnar Mellgren
Journal:  Obes Surg       Date:  2013-01       Impact factor: 4.129

Review 8.  Metabolic surgery-principles and current concepts.

Authors:  M Gass; C Beglinger; R Peterli
Journal:  Langenbecks Arch Surg       Date:  2011-08-26       Impact factor: 3.445

Review 9.  Bariatric surgery: risks and rewards.

Authors:  Walter J Pories
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

Review 10.  Effects of bariatric surgery on glucose homeostasis and type 2 diabetes.

Authors:  David Bradley; Faidon Magkos; Samuel Klein
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.